HGF and MET: from brain development to neurological disorders
Peptide Information MOTS-c Research Research on MOTS-c is still relatively new, but it has attracted significant interest for potential applications in treating metabolic disorders, obesity, diabetes, and possibly age-related conditions
Pregnant or breastfeeding women, individuals with active malignancy, and those with bleeding disorders should not use BPC-157
The guidance around the management of B12 deficiency in people treated with metformin is a little unclear, owing to a lack of clinical evidence in this area
Capsulated BPC-157 is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency